Align Technology | ALGN - Ebitda


Align Technology reported $260.87M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
3M USD 1.42B 8M Mar/2026
Align Technology USD 260.87M 77.03M Dec/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Bruker USD 110M 101.6M Mar/2026
Cardinal Health USD 1.09B 109M Mar/2026
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Cooper Companies USD 323.4M 13.2M Dec/2025
CVS Health USD 5.83B 2.08B Mar/2026
Danaher USD 1.92B 204M Mar/2026
Dentsply International USD 129M 6M Mar/2026
Dexcom USD 364.5M 57.7M Mar/2026
Henry Schein USD 289M 2M Mar/2026
Idexx Laboratories USD 400.87M 45.95M Mar/2026
Insulet USD 181.7M 12.3M Mar/2026
Integra LifeSciences USD 76.18M 28.03M Mar/2026
IQVIA Holdings USD 932M 114M Mar/2026
Masimo USD 85.5M 6.4M Mar/2026
McKesson USD 1.88B 206M Dec/2025
Mettler Toledo International USD 278.99M 100.24M Mar/2026
Revvity USD 272.91M 24M Mar/2026
Solventum Corp USD 437M 0 Mar/2026
Stryker USD 1.57B 618M Mar/2026
Teleflex USD 247.07M 575.88M Dec/2025
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
Veeva Systems USD 403.96M 29.17M Mar/2026
Waters USD 380.97M 85.83M Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025
Zoetis USD 939M 101M Dec/2025